Drugs for cancer and copayments.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 18595953.
- Also identified by DOI 10.1136/bmj.a527 and PMC identifier 2443555.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Principles underpinning copayments must preserve equity, be transparent, and enhance knowledge on treatment outcomes
Medical subject headings
- Antineoplastic Agents
- Neoplasms